Impact of deleterious germline BRCA mutations, addition of taxanes and use of adjuvant endocrine therapy (ET) on anti-müllerian hormone (AMH) levels in early breast cancer (EBC) patients treated by adjuvant chemotherapy (CT)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 29; p. viii77
Main Authors Olympios, N., Lambertini, M., Calbrix, C., Saint-Ghislain, M., Fontanilles, M., Loeb, A., Leheurteur, M., Demeestere, I., Di Fiore, F., Perdrix, A., Clatot, F.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2018
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy270.237